<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Tue, 23 Sep 2025 13:15:02 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Eating Disorder Charities Warn of Weight Loss Drug Dangers</title><link>https://www.medscape.com/viewarticle/eating-disorder-charities-warn-weight-loss-drug-dangers-2025a1000pdi?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Weight-loss injections are booming in popularity but eating disorder experts in the UK warn the trend is fuelling dangerous behaviours and glamourisin...</description><pubDate>Tue, 23 Sep 2025 18:04:02 GMT</pubDate></item><item><title>Europe: B-Cell Therapy Moves Into IgG4-Related Disease</title><link>https://www.medscape.com/viewarticle/europe-b-cell-therapy-moves-igg4-related-disease-2025a1000pdk?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>The therapy targets CD19+ B cells, offering a new mechanism for managing this multiorgan fibroinflammatory disease. Medscape Medical News</description><pubDate>Tue, 23 Sep 2025 17:41:11 GMT</pubDate></item><item><title>EMA Backs COVID Booster for LP.8.1, Expands to Teens</title><link>https://www.medscape.com/viewarticle/ema-backs-covid-booster-lp-8-1-expands-teens-2025a1000pda?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>The protein-based vaccine now covers the LP.8.1 variant and can be given to adolescents aged 12 years or older who previously received mRNA vaccines. ...</description><pubDate>Tue, 23 Sep 2025 17:20:04 GMT</pubDate></item><item><title>FDA OKs Tremfya for Ulcerative Colitis</title><link>https://www.medscape.com/viewarticle/fda-oks-tremfya-ulcerative-colitis-2025a1000pd0?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Phase 3 data showed comparable safety and efficacy of subcutaneous and intravenous induction regimens of guselkumab for moderately to severely active ...</description><pubDate>Tue, 23 Sep 2025 17:05:26 GMT</pubDate></item><item><title>EMA Endorses Generic Blood Thinner in New Formulation</title><link>https://www.medscape.com/viewarticle/ema-endorses-generic-blood-thinner-new-formulation-2025a1000pcz?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>The orodispersible film formulation offers new dosing options for preventing clots and treating thrombotic events across adult and pediatric populatio...</description><pubDate>Tue, 23 Sep 2025 15:57:30 GMT</pubDate></item></channel></rss>